Scientists by trade. Explorers at heart.
3000+ people. More than 20 global locations. One expert team. Everything we do—from the services we offer to the products we provide—is made possible by our people. Our team of experts, innovators and leaders has helped hundreds of clients navigate complex R&D and manufacturing challenges. Now, we await yours.
A team you can count on
Quality and regulatory specialists
Our leadership team
Discover the latest from our thought leaders
In the fall of 2021, the Delta variant of SARS-CoV-2 was the dominant strain in the US, being both more contagious than previous variants and more likely to lead to “long COVID” than subsequent Omicron variants. Here we describe the discovery and characterization of a large number of Delta spike-binding monoclonal antibodies (mAbs). By combining detailed DNA sequence analysis and binding assays, we identified 96 candidates for further analysis and development. Many of these hits exhibited neutralizing activity and also cross-reacted with one or more of the wild-type virus, Omicron 1.1.529, BA.2 and BA.5 variants.
To say that “our lives are busier than ever” would be a redundant statement. The good news is: we still have 24 hours in each day! Curia’s Director, Learning & Development, Terri Souder-Basa put together a practical guide on how to overcome a “lack of time” challenge to help us focus on the right things.